跳至主要内容
临床试验/NCT03016364
NCT03016364Unknown1 期

Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain

Cancer Institute and Hospital, Chinese Academy of Medical Sciences1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年1月最近更新:
适应症
干预措施

试验速览

阶段
1 期
入组人数
200
试验地点
1
主要终点
Numerical Pain Rating Scale

研究概览

简要总结

The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • a histologically confirmed diagnosis of Cancer or Sarcoma
  • advanced patients with severe cancer pain(score >3)
  • having used or expected to use the Oxycodone Hydrochloride Prolonged-release Tablets

排除标准

  • allergic to Oxycodone Hydrochloride Prolonged-release Tablets, or other reasons (determined by clinical doctors) unable to use the Opioids

研究组 & 干预措施

APP in dosage adjustment

Experimental

Through the guidance of APP software, clinical doctors try to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets for advanced patient's with cancer pain.

干预措施: APP software (Device)

结局指标

主要结局

Numerical Pain Rating Scale

时间窗: upto 8 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peng Liu

Attending Physician

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

研究点 (1)

Loading locations...

相似试验